Related Experiment Video
Updated: Oct 11, 2025
07:50
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
5.7K
Methylation Profiling of Specific Genes in Ependymomas
Naz Kanit1, Pelin Yalcin, Serhat Erbayraktar
1Department of Molecular Medicine, Dokuz Eylul University Institute of Health Sciences, IZMIR, TURKEY.
Turk Patoloji Dergisi
|December 2, 2021
Summary
DNA methylation changes in ependymomas are important. ZIC2 and RASSF1A gene methylation may help classify these central nervous system tumors, particularly RASSF1A in high-grade spinal tumors.
Area of Science:
- Neuro-oncology
- Molecular biology
- Cancer epigenetics
Background:
- Ependymomas are diverse central nervous system tumors.
- Understanding their molecular basis is crucial for classification and treatment.
Purpose of the Study:
- To investigate the correlation between DNA methylation status of specific genes and clinicopathological features of ependymomas.
- To explore the potential of methylation profiles in subtyping these tumors.
Main Methods:
- Quantitative pyrosequencing of CDKN2A, RASSF1A, KLF4, and ZIC2 gene methylation in 44 ependymoma tissues.
- Statistical analysis of methylation profiles against tumor subtype, histological grade, and patient age.
Main Results:
- ZIC2 hypermethylation was significantly associated with adult spinal ependymomas.
- RASSF1A hypermethylation correlated with grade 3 histology and spinal ependymomas, notably in pediatric and adult cases.
- No significant associations were found for KLF4 methylation with clinicopathological parameters.
Conclusions:
- DNA methylation alterations play a role in ependymoma biology.
- ZIC2 and RASSF1A methylation patterns show promise as biomarkers for ependymoma subclassification.
